This exploratory, prospective, open-label, single-centre, safety, efficacy and in-use tolerability study of the test product in healthy adult human subjects with dry or sensitive skin.
Age: 18 to 55 years (both inclusive) at the time of consent.
Sex: Healthy male and non-pregnant/non-lactating females.
Females of childbearing potential must have a self-reported negative pregnancy test.
Subject are generally in good health.
History of any dermatological condition of the skin diseases.
Subject with present condition of allergic response to any cosmetic product.
Subject having allergic response to the ink.
Presence of any broken, chapped, cut, irritated, or scraped skin at the application site.